Rock Springs Capital Management’s Collegium Pharmaceutical COLL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-562,000
| Closed | -$21.8M | – | 116 |
|
|
2024
Q1 | $21.8M | Hold |
562,000
| – | – | 0.55% | 55 |
|
|
2023
Q4 | $17.3M | Hold |
562,000
| – | – | 0.43% | 62 |
|
|
2023
Q3 | $12.6M | Sell |
562,000
-88,000
| -14% | -$2.01M | 0.34% | 67 |
|
|
2023
Q2 | $14M | Hold |
650,000
| – | – | 0.33% | 69 |
|
|
2023
Q1 | $15.6M | Sell |
650,000
-75,000
| -10% | -$1.99M | 0.37% | 66 |
|
|
2022
Q4 | $16.8M | Hold |
725,000
| – | – | 0.4% | 63 |
|
|
2022
Q3 | $11.6M | Hold |
725,000
| – | – | 0.3% | 73 |
|
|
2022
Q2 | $12.8M | Hold |
725,000
| – | – | 0.37% | 67 |
|
|
2022
Q1 | $14.8M | Hold |
725,000
| – | – | 0.37% | 69 |
|
|
2021
Q4 | $13.5M | Sell |
725,000
-175,000
| -19% | -$3.41M | 0.31% | 80 |
|
|
2021
Q3 | $17.8M | Sell |
900,000
-20,000
| -2% | -$432K | 0.37% | 77 |
|
|
2021
Q2 | $21.7M | Hold |
920,000
| – | – | 0.43% | 71 |
|
|
2021
Q1 | $21.8M | Sell |
920,000
-180,000
| -16% | -$4.28M | 0.48% | 69 |
|
|
2020
Q4 | $22M | Sell |
1,100,000
-75,000
| -6% | -$1.46M | 0.47% | 75 |
|
|
2020
Q3 | $24.5M | Hold |
1,175,000
| – | – | 0.62% | 55 |
|
|
2020
Q2 | $20.6M | Hold |
1,175,000
| – | – | 0.56% | 60 |
|
|
2020
Q1 | $19.2M | Sell |
1,175,000
-400,000
| -25% | -$8.26M | 0.79% | 45 |
|
|
2019
Q4 | $32.4M | Sell |
1,575,000
-2,893
| -0.2% | -$48.2K | 1.02% | 32 |
|
|
2019
Q3 | $18.1M | Hold |
1,577,893
| – | – | 0.72% | 53 |
|
|
2019
Q2 | $20.7M | Hold |
1,577,893
| – | – | 0.75% | 51 |
|
|
2019
Q1 | $23.9M | Sell |
1,577,893
-27,212
| -2% | -$436K | 0.92% | 36 |
|
|
2018
Q4 | $27.6M | Sell |
1,605,105
-44,995
| -3% | -$770K | 1.3% | 21 |
|
|
2018
Q3 | $24.3M | Buy |
1,650,100
+100
| +0% | +$1.77K | 0.88% | 37 |
|
|
2018
Q2 | $39.4M | Sell |
1,650,000
-270,000
| -14% | -$6.64M | 1.51% | 14 |
|
|
2018
Q1 | $49.1M | Buy |
1,920,000
+34,271
| +2% | +$817K | 2.09% | 7 |
|
|
2017
Q4 | $34.8M | Buy |
1,885,729
+80,729
| +4% | +$1.16M | 1.58% | 16 |
|
|
2017
Q3 | $18.9M | Buy |
1,805,000
+6,805
| +0.4% | +$75K | 0.87% | 42 |
|
|
2017
Q2 | $22.5M | Buy |
1,798,195
+98,195
| +6% | +$970K | 1.14% | 25 |
|
|
2017
Q1 | $17.1M | Buy |
1,700,000
+100,000
| +6% | +$1.49M | 0.99% | 35 |
|
|
2016
Q4 | $24.9M | Buy |
1,600,000
+55,000
| +4% | +$914K | 1.67% | 18 |
|
|
2016
Q3 | $29.8M | Buy |
1,545,000
+330,000
| +27% | +$3.92M | 1.87% | 15 |
|
|
2016
Q2 | $14.4M | Buy |
1,215,000
+70,000
| +6% | +$1.16M | 1.07% | 31 |
|
|
2016
Q1 | $20.8M | Buy |
1,145,000
+139,513
| +14% | +$2.54M | 1.74% | 15 |
|
|
2015
Q4 | $27.7M | Buy |
1,005,487
+11,087
| +1% | +$234K | 2.1% | 10 |
|
|
2015
Q3 | $22M | Buy |
994,400
+239,800
| +32% | +$4.34M | 1.78% | 12 |
|
|
2015
Q2 | $13.5M | Buy |
+754,600
| New | +$13M | 0.98% | 32 |
|
Other funds holding COLL
EAM
RCMNY
Rock Springs Capital Management's COLL Position: Q2 2024 in Review
Rock Springs Capital Management sold out of Collegium Pharmaceutical (COLL) in Q2 2024, closing a stake of 562,000 shares — an estimated $21.8M sold.
Rock Springs Capital Management first reported a position in COLL in Q2 2015 and held it in 36 quarters. The position peaked at $49.1M in Q1 2018. 229 funds tracked by Wall St. Rank hold COLL as of Q2 2024.
- Rock Springs Capital Management reported no remaining Collegium Pharmaceutical position as of Q2 2024 after selling out during the quarter.
- Rock Springs Capital Management sold 562,000 Collegium Pharmaceutical shares in Q2 2024, an estimated $21.8M.
- Rock Springs Capital Management first reported a position in Collegium Pharmaceutical in Q2 2015 and held it in 36 quarters.
- Rock Springs Capital Management's Collegium Pharmaceutical position peaked at $49.1M in Q1 2018.
- 229 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2024.
Based on Rock Springs Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.